| Document |
Document Title |
|
WO/2017/038954A1 |
The present invention relates to a tetramethyl biphenolic epoxy resin represented by formula (1), and relates to an epoxy resin which has excellent solubility in a solvent and contains a small amount of hydrolyzable chlorine, while havin...
|
|
WO/2017/038979A1 |
Provided are: a compound represented by formula (1) and a method for producing same; a composition; a composition for forming an optical component; a composition for forming a lithographic film; a resist composition; a method for forming...
|
|
WO/2017/035099A1 |
The present specification discloses pest control compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a population of invertebrate pests from a mammal, location, plant, s...
|
|
WO/2017/027388A1 |
Disclosed herein are the conversion of estolide compounds having unsaturated fatty acid groups into estolides containing cyclic carbonate moieties and methods of making and using the same. The estolides containing a cyclic carbonate may ...
|
|
WO/2017/020124A1 |
A method for the preparation of polyol from an unsaturated TAG oil that can function similarly to castor oil in certain applications. The method comprises controlled epoxidation of the TAG oil with an acid and an oxidizing agent to obtai...
|
|
WO/2017/024009A1 |
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and...
|
|
WO/2017/017307A1 |
The invention relates to a method for producing glycidol in a semi-continuous or continuous manner by means of decarboxylation of glycerol carbonate at a reduced pressure, at a temperature less than or equal to 130ºC and in the presence...
|
|
WO/2017/018489A1 |
Provided are: a fluorine-containing compound that can obtain a cured product having excellent heat resistance, a superior ability to be released from molds, and a high Abbe number; a curable composition that includes the compound; and a ...
|
|
WO/2017/004349A2 |
The present invention provides methods for the production of terephthalic acid and derivatives thereof using ethylene oxide, carbon monoxide and furan as feedstocks. The process is characterized by high yields and high carbon efficiency....
|
|
WO/2016/208699A1 |
[Problem] To provide a method for the industrial production of an optically active fluoroalkyl ethylene oxide. [Solution] An optically active fluoroalkyl chloromethyl alcohol having a high optical purity can be produced at a high yield b...
|
|
WO/2016/202807A1 |
The present invention relates to a process for providing substituted phenyl ketones wherein a Grignard reagent which is obtained from a substituted phenyl bromide is reacted with an acyl chloride at a temperature of -20 to 10 °C. Furthe...
|
|
WO/2016/192631A1 |
The present invention provides an abietane-type diterpene compound having lipid-lowering activity, a method for preparing same, and use of same. Specifically, the compound has the structure shown in formula I. The definitions of the grou...
|
|
WO/2016/196767A1 |
A method is provided for improving the performance of a silver-based epoxidation catalyst comprising a carrier. The carrier includes at least 80 percent alpha alumina and has a pore volume from 0.3 mL/g to 1.2 mL/g, a surface area from 0...
|
|
WO/2016/190354A1 |
The purpose of the present invention is to provide a novel compound which is useful as a plasticizer that has improved heat resistance and cold resistance, while having good inherent plasticization performance as a plasticizer, or which ...
|
|
WO/2016/183809A1 |
The present invention relates to a nebivolol synthesis method and intermediate compound thereof. Specifically, the present invention relates to a method for synthesizing nebivolol, intermediate compound thereof and method for preparing t...
|
|
WO/2016/185450A1 |
The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
|
|
WO/2016/184038A1 |
Disclosed is a method for preparing cyclohexene oxide using a micro-flow field reaction technology. The method is a method for preparing cyclohexene oxide from raw materials such as m-chlorobenzoyl chloride, an aqueous hydrogen peroxide ...
|
|
WO/2016/180642A1 |
The present invention relates to a process for the preparation of terpinolene epoxide by epoxidation of terpinolene.
|
|
WO/2016/173887A1 |
In a process for the epoxidation of propene, comprising the steps: reacting propene with hydrogen peroxide in the presence of a titanium silicalite catalyst and a methanol solvent; separating non-reacted propene and propene oxide from th...
|
|
WO/2016/162646A1 |
The present invention relates to a method for preparing a precursor of a single dairy-lactone isomer, to a single dairy-lactone isomer, and to the organoleptic uses thereof.
|
|
WO/2016/164595A1 |
The present disclosure relates to a method of preparing propylene oxide comprising the steps: (a) oxidizing alpha-methylbenzyl alcohol with air to form a first reaction mixture comprising hydrogen peroxide and acetophenone; (b) reacting ...
|
|
WO/2016/144441A1 |
New uses of hypoestoxide, its derivatives and related compounds for treatment and prevention of neurodegenerative diseases (e.g. Parkinsons disease, Alzheimers disease, Huntingtons disease) are described. More specifically, the invention...
|
|
WO/2016/140459A1 |
The present invention provides: a novel structure of a phosphorus-based epoxy compound having a high phosphorus (P) content and having high heat resistance and low dielectric characteristics; a method for preparing a phosphorus-based epo...
|
|
WO/2016/134257A1 |
A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure: (I).
|
|
WO/2016/129561A1 |
Provided is a method for efficiently and safely producing a compound having an N,N-bis(2-hydroxy-3-chloropropyl)amino group on an industrial scale. A compound having an N,N-bis(2-hydroxy-3-chloropropyl)amino group is produced by continuo...
|
|
WO/2016/119848A1 |
The present invention relates to a method for preparing a cycloaliphatic epoxy resin and the thus prepared cycloaliphatic epoxy resins. The method includes the oxidiation of a cycloalkene compound with hydrogen peroxide in the presence o...
|
|
WO/2016/097657A2 |
The invention relates to a compound having the following Formula (I), wherein n and m are whole numbers from 0 to 6, selected independently from each other, and R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, selected independently from eac...
|
|
WO/2016/088138A1 |
The present invention discloses substituted diphenyloxiranes and process for synthesis thereof. The present invention also provides a process for production of enantiomerically pure anti-3,3'-diphenylmethyloxirane and anti-3,3'-diphenylp...
|
|
WO/2016/076112A1 |
Provided is a process for safely producing, in a high yield, a high-purity polyvalent glycidyl compound from a compound having one or more 2-alkenyl ether groups and two or more 2-alkenyl groups in the molecule, by using an aqueous hydro...
|
|
WO/2016/077264A1 |
The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of non-small-cell lung carcinoma (NSCLC) and for the treatment of glioblastoma multiforme (GBM). Dianhydrogalactitol acts as an alkylating agent on DN...
|
|
WO/2016/067010A1 |
The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteaso...
|
|
WO/2016/065576A1 |
The present invention provides a process for the preparation of high-purity guaiacol glycidyl ether of formula (I). The present invention further relates to an improved process for the purification of guaiacol glycidyl ether of formula (...
|
|
WO/2016/069266A1 |
The present disclosure is directed to a plasticizer composition, polymeric compositions containing the plasticizer composition, and coated conductors comprising the polymeric composition. The plasticizer composition comprises an epoxidiz...
|
|
WO/2016/063957A1 |
Provided are: a decalin derivative having a glycidyloxy group or an allyloxy group; and a method for producing the decalin derivative. A decalin derivative represented by formula (1) is produced by: a method comprising reacting a hydroxy...
|
|
WO/2016/050004A1 |
Disclosed is an olefin oxidation method. The method comprises the step of: under an olefin oxidation reaction condition, enabling feeds to sequentially flow through a first catalyst bed to an nth catalyst bed, wherein if apparent velocit...
|
|
WO/2016/047277A1 |
To reduce the generation of a by-product or to increase the selectivity in a reaction in a method for producing 3-chloro-2-hydroxypropyl (meth)acrylate and in a method for producing glycidyl (meth)acrylate, wherein the generation of a by...
|
|
WO/2016/039431A1 |
Provided is an electroconductive member for electrophotography in which movement of a quaternary ammonium salt toward the surface of a binder resin is suppressed and which exhibits a less reduction in electroconductivity through electrif...
|
|
WO/2016/033605A1 |
The present invention relates to a method of producing an improved asphalt. The method involves providing an asphalt and providing a compound of formula (I), as described herein. The asphalt is mixed with the compound of formula (I) unde...
|
|
WO/2016/032997A2 |
Disclosed herein is a method of making a 2-(2,3-epoxypropyl)phenol by reacting a 2-allylphenol with an oxidant in the presence of a catalyst. A 3-chromanol can be formed as a by-product. The method can be used to make 2-(2,3-epoxypropyl)...
|
|
WO/2016/016070A1 |
In a process for the epoxidation of an olefin, where a mixture comprising olefin, hydrogen peroxide, water and methanol with a weight ratio of water to methanol of less than 1 is passed through a catalyst fixed bed comprising a shaped ti...
|
|
WO/2016/014536A1 |
High purity epoxide compounds, methods for preparing the high purity epoxide compounds, and compositions derived from the epoxide compounds are provided. Also provided are materials and articles derived from the epoxide compounds.
|
|
WO/2016/011088A2 |
The present disclosure relates to novel compounds and pharmaceutical compositions thereof which are useful as inhibitors of proteasomes. The compounds provided herein have improved proteasome potency and selectivity, and increased aqueou...
|
|
WO/2016/005211A1 |
The present invention relates to a process for the preparation of oxirane compounds of formula II from keto compounds III using dimethyl sulfide (CH3)2S and dimethylsulfate (CH3)2SO4,forming the reagent IV, trimethylsulfonium methylsulfa...
|
|
WO/2016/001344A1 |
Dental composition comprising (a) at least two di- or polyepoxides having 2 to 5 epoxide groups and having a molecular weight of from 200 to 700 Da, or a macromonomeric reaction product obtainable by reacting the diepoxide with a dicarbo...
|
|
WO/2015/195776A1 |
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivaties that possess unique antiviral activity are provided as HIV maturation inhibi...
|
|
WO/2015/074025A9 |
An improved analytical method for analysis of dianhydrogalactitol preparations provides a method for determining the purity of dianhydrogalactitol and detecting impurities in preparations of dianhydrogalactitol, as well as identifying an...
|
|
WO/2015/174936A1 |
The invention relates to an improved process for making monomelic triglycidyl compounds, wherein the triglycidyl compounds include N, O-triglycidyl compounds containing at least one primary aromatic amine and one phenolic functional grou...
|
|
WO/2015/171589A1 |
The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effe...
|
|
WO/2015/168771A1 |
Methacrylated cardanol glycidyl ethers, diglycidyl ethers, intermediates and derivatives thereof are described herein. Compositions and polymers made with such compounds as well as methods of preparation thereof are also described. For e...
|
|
WO/2015/166860A1 |
To increase safety and reduce environmental load in the production of a nitrogen-containing heterocyclic compound. An oxirane compound represented by formula (1). (In formula (1), R1 represents an optionally substituted aryl group; at le...
|
